Respiratory tract infections (RTIs) are the focus of developments in public health, given their widespread distribution and the high morbidity and mortality rates reported worldwide. A range of bacterial, fungal and viral pathogens cause respiratory infections, highlighting the critical value of alert clinicians, strong laboratory networks and surveillance approaches to detect emerging threats and prevent spread.

SHANGHAI, CHINA, March 14, 2023—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “BioPerfectus”) is proud to launch the following 11 new Real Time PCR Kits independently developed by BioPerfectus. When combined with our extraction solution and PCR system, we could provide a Respiratory Infectious Diseases Total PCR Solution for the detection of respiratory pathogens.

Respiratory viruses are of particular concern as they typically have short incubation periods, causative agents include rhinoviruses, respiratory syncytial virus, influenza virus, parainfluenza virus, human metapneumovirus, measles, adenovirus, and coronaviruses. Consider also viruses of particular concern in travelers, including Middle East respiratory syndrome (MERS) coronavirus. They spread easily between people and possibly animals through infectious respiratory particles of various sizes (e.g., droplets and aerosols) without direct physical contact. Their rapid spread can result in high morbidity and mortality and have the potential to overwhelm healthcare systems and mortuary services. Some virus groups are also prone to high rates of virus evolution, which can lead to increased disease severity, and contribute to challenges for medical countermeasures.

Bacterial pathogens are less common than viral but can include Streptococcus pneumoniae, Mycoplasma pneumoniae, Haemophilus influenzae, and Chlamydophila pneumoniae. Legionella pneumophila and Coxiella burnetii can cause outbreaks and sporadic cases of respiratory illness.

Dedicated to providing laboratories with comprehensive respiratory infectious disease tests, BioPerfectus provides Respiratory Infectious Diseases Total Diagnostic Solutions from sample pre-processing to PCR amplification analysis. Pioneering in molecular diagnostics, BioPerfectus is always devoted to pursuing high quality, keeps innovating, and is committed to solving health problems faced by humankind for a healthier future.

Reference:

[1] WHO Severe Acute Respiratory Infections Treatment Centre. Practical Manual to Set Up and Manage a SARI Treatment Centre and a SARI Screening Facility in Health Care Facilities; World Health Organization: Geneva, Switzerland, 2020

[2] Miranda, M., Pingarilho, M., Pimentel, V., Torneri, A., Seabra, S., Libin, P., et al. (2022). A tale of three recent pandemics: Influenza, HIV and SARS-COV-2. Frontiers in Microbiology, 13, 889643. https://doi.org/10.3389/fmicb.2022.889643

[3] https://wwwnc.cdc.gov/travel/yellowbook/2020/posttravel-evaluation/respiratory-infections